Scottsdale, AZ (PRWEB) June 13, 2012
QualityStocks would like to highlight International Stem Cell Corporation, a publicly traded company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs).
In the company’s news yesterday,
International Stem Cell Corporation announced new sales and marketing initiatives for its stem cell based skin care products produced through subsidiary Lifeline Skin Care. New integrated advertising campaigns will be launched during June and July, in magazines, newspapers, and through direct mail, as well as online. Additional moves are being made through partners and other channels.
- Consumer Advertising – The online, newspaper, magazine, and direct mail campaigns will feature Lifeline’s innovative stem cell technology and proof of the brand’s potential for younger looking skin. Although the ads will eventually be national in reach, the first few months will be devoted to optimizing the creative approach, targeting, frequency, timing, positioning, offer, and ROI.
- Key Opinion Leader and Peer Group Influencer – Elizabeth K. Hale, MD, one of the nation’s top dermatologists, is now endorsing Lifeline Skin Care to both consumer and trade audiences. Dr. Hale is an Associate Clinical Professor of Dermatology at New York University, a private practitioner and a guest of the Doctor Oz show, the Today Show, and Good Morning America. During the week of June 4 she met with beauty editors for Prevention, Health, Town and Country, Allure, FoxNews.com, and InStyle, to present Lifeline Skin Care and its unique technology. The endorsement of a leading dermatologist should not only enhance the credibility of the brand but increase its visibility.
- Strategic Partners – Email campaigns through strategic partners have been very successful at marketing Lifeline products. To expand that effort, several new key opinion leaders have now agreed to endorse Lifeline Skin Care to their social networks, including Mrs. Jeri Thompson, a conservative spokesperson, radio and TV guest, and advocate for non-embryonic stem cell research; and authors, experts, and media personalities in the areas of women’s health, yoga, cosmetic dentistry, and retirement planning. Many of these partners plan to market Lifeline through their social network (email marketing, blogs, Facebook, etc.) as well as through personal and radio appearances. Most of these campaigns will launch during the third quarter.
- Professional Channels – During the week of June 12, Lifeline is launching two campaigns directed to 27,000 cosmetic dermatologists and day spas. These campaigns are focused on providing information to skin care professionals, including dermatologists and plastic surgeons, to understand and embrace the significance and value of stem cell extracts for skin rejuvenation.
Newly appointed President and CEO of Lifeline Skin Care, Donna Queen, said: “We intend to take the leadership role and intend to make Lifeline own the stem cell skin care category.”
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.